Shu Zhang

The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4

Li Liu, Patrick A. Mayes, Stephen D. Eastman et al. · Clinical Cancer Research · 2015 · 447 citations

Medicine, Immunology, Oncology +17

Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

Richard G. Wunderink, Evangelos J. Giamarellos‐Bourboulis, Galia Rahav et al. · Infectious Diseases and Therapy · 2018 · 442 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Precision treatment in advanced hepatocellular carcinoma

Xupeng Yang, Chen Yang, Shu Zhang et al. · Cancer Cell · 2024 · 393 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity

Won Jin Ho, Qingfeng Zhu, Jennifer N. Durham et al. · Nature Cancer · 2021 · 346 citations · Full text

Medicine, Oncology, Pharmacology +17

Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma

Liangqing Dong, Lihua Peng, Lijie Ma et al. · Journal of Hepatology · 2019 · 262 citations

Medicine, Immunology, Oncology +16